McKesson Corporation (MCK) Shares Slide -1.02%

McKesson Corporation (MCK) has risen sharply, recording gains of 3.43% in the past 4 weeks. However, the stock has corrected -1.02% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 0.07% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.

The stock has recorded a 20-day Moving Average of 0.05% and the 50-Day Moving Average is 4.07%. McKesson Corporation is up 16.11% in the last 3-month period. Year-to-Date the stock performance stands at -1.03%.


McKesson Corporation (NYSE:MCK): stock turned positive on Friday. Though the stock opened at $192.79, the bulls momentum made the stock top out at $195.13 level for the day. The stock recorded a low of $191.2 and closed the trading day at $194.56, in the green by 0.58%. The total traded volume for the day was 1,440,093. The stock had closed at $193.44 in the previous days trading.

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.